Treatment of Congestive Heart failure
... treatment of heart failure, either on its own or in addition to standard medical treatment. Hawthorn increases the strength of the heart’s contraction (inotropic effect similar to that exhibited by digoxin). It also increases blood flow in the heart, increases left ventricular ejection fraction and ...
... treatment of heart failure, either on its own or in addition to standard medical treatment. Hawthorn increases the strength of the heart’s contraction (inotropic effect similar to that exhibited by digoxin). It also increases blood flow in the heart, increases left ventricular ejection fraction and ...
Document
... more than one century ago. In a 1997 article, Rost8 explains that Henschen examined a group of crosscountry skiers in 1899 and found that those with bigger heart performed better in this endurance event. Henschen used finger percussion to estimate heart size and introduced the phrase “the athlete’s h ...
... more than one century ago. In a 1997 article, Rost8 explains that Henschen examined a group of crosscountry skiers in 1899 and found that those with bigger heart performed better in this endurance event. Henschen used finger percussion to estimate heart size and introduced the phrase “the athlete’s h ...
Pulmonary Hypertension
... Natural History The natural history of IPAH is uncertain, but the disease typically is diagnosed late in its course. Before current therapies, a mean survival of 2–3 years from the time of diagnosis was reported. The cause of death is usually RV failure, which is manifest by progressive hypoxemia ...
... Natural History The natural history of IPAH is uncertain, but the disease typically is diagnosed late in its course. Before current therapies, a mean survival of 2–3 years from the time of diagnosis was reported. The cause of death is usually RV failure, which is manifest by progressive hypoxemia ...
WellStar Structural Heart and Valve Program
... WellStar Kennestone Hospital, Marietta, GA Patient presentation/overview: Eighty-nine year old female with severe aortic stenosis, presented to the hospital on multiple occasions with CHF exacerbations. PMH includes CAD s/p PCI to LAD and RCA with DES 10/2014, PAF, breast CA s/p L mastectomy with ch ...
... WellStar Kennestone Hospital, Marietta, GA Patient presentation/overview: Eighty-nine year old female with severe aortic stenosis, presented to the hospital on multiple occasions with CHF exacerbations. PMH includes CAD s/p PCI to LAD and RCA with DES 10/2014, PAF, breast CA s/p L mastectomy with ch ...
Basic Physiology and Approach to Heart
... exceeds atrial pressure, the AV valves close which results in the first heart sound, S1, or the “lub”. After the AV valves close, the ventricular pressure rises rapidly as the ventricles are contracting against closed aortic and pulmonic valves. As there is no net movement of volume in or out of the ...
... exceeds atrial pressure, the AV valves close which results in the first heart sound, S1, or the “lub”. After the AV valves close, the ventricular pressure rises rapidly as the ventricles are contracting against closed aortic and pulmonic valves. As there is no net movement of volume in or out of the ...
the PDF - Heart Rhythm Society
... Heart failure (HF) is a clinical syndrome comprised of symptoms and signs associated with congestion and/or hypoperfusion. It can result from any structural or functional cardiac disorder that impairs the ability of the ventricles to eject blood (systolic dysfunction), to fill properly (diastolic dy ...
... Heart failure (HF) is a clinical syndrome comprised of symptoms and signs associated with congestion and/or hypoperfusion. It can result from any structural or functional cardiac disorder that impairs the ability of the ventricles to eject blood (systolic dysfunction), to fill properly (diastolic dy ...
Orthotopic heart transplant following implantation of a
... obstructions such as an additional papillary muscle with accompanying chordae, trabeculations, and the moderator band. Using TEE guidance, these must be considered when determining placement of the VAD to prevent inflow obstruction. With the introduction of smaller devices, placement of VADs in this ...
... obstructions such as an additional papillary muscle with accompanying chordae, trabeculations, and the moderator band. Using TEE guidance, these must be considered when determining placement of the VAD to prevent inflow obstruction. With the introduction of smaller devices, placement of VADs in this ...
Cardiac magnetic resonance imaging of systemic amyloidosis
... of restricted diastolic function and assessment of disproportionate atrial enlargement. These physiological changes indicate that deposition of amyloid fibrils in myocardial tissue results in reduced ventricular compliance, impairment of relaxation and eventually contraction.13,15 Of the patients wi ...
... of restricted diastolic function and assessment of disproportionate atrial enlargement. These physiological changes indicate that deposition of amyloid fibrils in myocardial tissue results in reduced ventricular compliance, impairment of relaxation and eventually contraction.13,15 Of the patients wi ...
Impact of Longitudinal Myocardial Deformation on the Prognosis of
... Background—Longitudinal myocardial deformation indexes appear superior to left ventricular ejection fraction (LVEF) in assessing myocardial contractility. However, few studies have addressed the prognostic value of longitudinal motion markers (velocity, strain, and strain rate) in predicting outcome ...
... Background—Longitudinal myocardial deformation indexes appear superior to left ventricular ejection fraction (LVEF) in assessing myocardial contractility. However, few studies have addressed the prognostic value of longitudinal motion markers (velocity, strain, and strain rate) in predicting outcome ...
patient information - AF Ablation Clinic
... Atrial Flutter is an abnormal heart rhythm within the upper pumping chambers of the heart (left and right atria) and falls into the category of supra ventricular tachycardia (fast rhythms in the upper chambers of the heart). This rhythm may occur in individuals with or without other forms of cardiov ...
... Atrial Flutter is an abnormal heart rhythm within the upper pumping chambers of the heart (left and right atria) and falls into the category of supra ventricular tachycardia (fast rhythms in the upper chambers of the heart). This rhythm may occur in individuals with or without other forms of cardiov ...
Chordate heart evolution: A basal view
... Why study Ciona? Why study Ciona heart development? Mesp regulation Mesp function ...
... Why study Ciona? Why study Ciona heart development? Mesp regulation Mesp function ...
Electrophysiology Pacemaker Worksheet
... Electrophysiology Pacemaker Worksheet 3. Seen on the ECG monitor is an absence of pacemaker spikes even though the patient’s intrinsic rate is less than that of the pacemaker and a return of the underlying rhythm for which the pacemaker was implanted is known as a. Failure to pace b. Failure to sen ...
... Electrophysiology Pacemaker Worksheet 3. Seen on the ECG monitor is an absence of pacemaker spikes even though the patient’s intrinsic rate is less than that of the pacemaker and a return of the underlying rhythm for which the pacemaker was implanted is known as a. Failure to pace b. Failure to sen ...
Machine Learning Approaches for Supporting Patient
... early mobilization and education to life-style changes and do not include an exercise training component. Outpatient hospital-based programs last from two to four months. The content of phase II cardiac rehabilitation varies greatly from hospital to hospital and it usually includes single or group e ...
... early mobilization and education to life-style changes and do not include an exercise training component. Outpatient hospital-based programs last from two to four months. The content of phase II cardiac rehabilitation varies greatly from hospital to hospital and it usually includes single or group e ...
Recent Advances in Noninvasive Cardiac Imaging
... in the realm of measuring fractional flow reserve (FFR) from angiography. This has been studied in several multi-center trials recently such as NXT [21] and PLATFORM [22]. These have shown ...
... in the realm of measuring fractional flow reserve (FFR) from angiography. This has been studied in several multi-center trials recently such as NXT [21] and PLATFORM [22]. These have shown ...
MCQs - cardiovascular1
... a) ischemic chest pain for at least 30 minutes b) ST elevation of at least 2 mm or more it two or more consecutive chest leads c) ST elevation of at least 2 mm or more it two or more consecutive limb leads d) New LBBB e) Elevation of the blood cardiac enzyme levels 9.Which is not an absolute contrai ...
... a) ischemic chest pain for at least 30 minutes b) ST elevation of at least 2 mm or more it two or more consecutive chest leads c) ST elevation of at least 2 mm or more it two or more consecutive limb leads d) New LBBB e) Elevation of the blood cardiac enzyme levels 9.Which is not an absolute contrai ...
predictors of survival for more than one year in
... Method: Clinical, ECG, echo and mortality data of 172 pts with histologically proven primary amyloidosis were studied. Results: 121 pts (age: 60+13.7 yrs; male, 66%) had CA (57 pts had positive cardiac biopsy or autopsy, and 64 pts had CA by clinical criteria [CHF with LVH or low voltage ECG]). The ...
... Method: Clinical, ECG, echo and mortality data of 172 pts with histologically proven primary amyloidosis were studied. Results: 121 pts (age: 60+13.7 yrs; male, 66%) had CA (57 pts had positive cardiac biopsy or autopsy, and 64 pts had CA by clinical criteria [CHF with LVH or low voltage ECG]). The ...
Selection of patients for cardiac transplantation
... new antiviral agents may lead to even better statistics. In our own program, in the last 30 consecutive patients starting in June 1985, there has been only one death. Cardiac transplantation now offers a better chance of survival than conventional surgical procedures performed on "high-risk" patient ...
... new antiviral agents may lead to even better statistics. In our own program, in the last 30 consecutive patients starting in June 1985, there has been only one death. Cardiac transplantation now offers a better chance of survival than conventional surgical procedures performed on "high-risk" patient ...
Ventricular hypertrophy icd 10
... external resources; ICD-10: I25.3: ICD-9-CM: 414.1: MeSH: D006322 H disease Haas' disease or osteochondrosis Habit, habituation Hachimycin Haemophilus influenzae, as cause of disease classified elsewhere Haff disease. Abstract and Introduction Abstract. Half of patients with heart failure (HF) have ...
... external resources; ICD-10: I25.3: ICD-9-CM: 414.1: MeSH: D006322 H disease Haas' disease or osteochondrosis Habit, habituation Hachimycin Haemophilus influenzae, as cause of disease classified elsewhere Haff disease. Abstract and Introduction Abstract. Half of patients with heart failure (HF) have ...
Second degree AV block and severely impaired contractility in
... hypertension, lowered cardiac output, impaired left ventricular contractility and diastolic relaxation, pericardial effusion and bradycardia. However, the function of the atrial pacemaker is usually normal and the degree by which the heart rate slows down is often modest. Here we report the case of ...
... hypertension, lowered cardiac output, impaired left ventricular contractility and diastolic relaxation, pericardial effusion and bradycardia. However, the function of the atrial pacemaker is usually normal and the degree by which the heart rate slows down is often modest. Here we report the case of ...
Freedom® Portable Driver
... of AVWS that is quickly and completely reversed after device explantation.” ...
... of AVWS that is quickly and completely reversed after device explantation.” ...
C
... sudden death in most instances (64%) and heart failure deterioration in the remainder. Therefore not everyone responds and some patients rapidly deteriorate no matter the therapeutic efforts, and for them, if suitable, heart transplantation is the only option. Beta blockade and angiotensin-convertin ...
... sudden death in most instances (64%) and heart failure deterioration in the remainder. Therefore not everyone responds and some patients rapidly deteriorate no matter the therapeutic efforts, and for them, if suitable, heart transplantation is the only option. Beta blockade and angiotensin-convertin ...
Arteries - LPS.org
... Myocardium – cardiac muscle layer forming the bulk of the heart Fibrous skeleton of the heart – crisscrossing, interlacing layer of connective tissue Endocardium – endothelial layer of the inner ...
... Myocardium – cardiac muscle layer forming the bulk of the heart Fibrous skeleton of the heart – crisscrossing, interlacing layer of connective tissue Endocardium – endothelial layer of the inner ...
The healthy heart - Blackwell Publishing
... not contract properly, it cannot hold an adequate quantity of blood for a heartbeat. Heart failure is typically treated with drugs, but biventricular device therapy (sometimes called cardiac resynchronization therapy or CRT) holds enormous promise, at least for certain types of patients. • Conductio ...
... not contract properly, it cannot hold an adequate quantity of blood for a heartbeat. Heart failure is typically treated with drugs, but biventricular device therapy (sometimes called cardiac resynchronization therapy or CRT) holds enormous promise, at least for certain types of patients. • Conductio ...
Mountaineering with
... Advise patients that they may become symptomatic at lower exercise workloads at high altitudes (>2500 meters) Limit activity at moderate or high altitudes to a lower maximal level than typically performed at sea level (80-90%), especially true during the first few days at altitude ...
... Advise patients that they may become symptomatic at lower exercise workloads at high altitudes (>2500 meters) Limit activity at moderate or high altitudes to a lower maximal level than typically performed at sea level (80-90%), especially true during the first few days at altitude ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.